Advisory committees cannot support public trust in FDA decisions if the agency uses them inconsistently. Simple reforms could improve accountability, transparency, and trust.
No takes yet. Share an insight, caveat, or question.
Daval et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: